Impressive Returns in 3M Call Options

Bullish option traders are logging impressive gains in 3M Company (MMM) today as the industrial conglomerate’s turnaround narrative continues to gain traction.

On Dec. 8, our Unusual Option Activity tracking systems identified significant bullish call buying, with 3,000 19December 167.50 calls bought in one order for $1.50 above the existing open interest of 86 contracts, with MMM shares trading at $164.17-$164.35.

Those 19December 167.50 calls traded as high as $3.85 today with the stock at $169.92, delivering impressive returns of approximately 156.67% from the initial entry price of $1.50. Meanwhile, MMM shares gained approximately 3.45% from their initial midpoint trading level around $164.26, demonstrating how options can deliver significantly amplified returns compared to simply owning the underlying stock.

This performance illustrates the power of options leverage when the directional thesis proves correct, though it’s important to note that this same leverage can work against traders when market moves go in the opposite direction.

Turnaround Momentum Drives Sustained Rally

The timing of the December 8th call buying proved strategically sound, as 3M has been riding a powerful multi-month rally driven by operational improvements and successful restructuring efforts. The stock hit a new 52-week high of $174.69 on December 3rd, 2025, reflecting investor confidence in the company’s transformation following the healthcare spin-off and progress on resolving legacy liabilities.

The sustained momentum stems from 3M’s strong third-quarter results announced on October 21st, where the company reported sales of $6.5 billion, up 3.5% year-over-year, with adjusted operating income margin of 24.7%, an impressive 170 basis point expansion. Adjusted earnings per share of $2.19 grew 10% year-over-year, demonstrating the effectiveness of management’s cost-cutting initiatives. Based on the strong performance, management increased full-year 2025 adjusted operating income margin expansion guidance to 180-200 basis points and raised the adjusted EPS midpoint.

Analyst Support Validates Long-Term Recovery

Just days before the unusual call buying activity, on December 4th, 2025, Barclays raised its price target on 3M to $190 from $180 while reaffirming a Buy rating. The upgrade reflected confidence in the company’s ability to sustain margin expansion and deliver on its restructuring initiatives despite ongoing legal challenges related to PFAS litigation.

The Barclays endorsement came alongside reports that “parts” of 3M’s portfolio were performing well, with CEO William Brown using his Goldman Sachs Industrials & Materials Conference presentation on December 4th to update investors on PFAS exit progress, margin sustainability, and capital allocation priorities. The conference appearance provided another platform for management to showcase the company’s operational resilience.

Call Buying Volume Signals Institutional Conviction

Notably, on December 8th itself—the same day as the unusual call buying identified by Market Rebellion—TipRanks reported that “3M call volume above normal and directionally bullish,” suggesting broader institutional interest in positioning for continued upside. This unusual options flow occurred despite a Deutsche Bank downgrade from Buy to Hold that same morning, demonstrating that many market participants viewed the stock’s fundamental momentum as more important than one analyst’s more cautious stance.

The Deutsche Bank downgrade, which lowered the price target to $178 from $199, cited “limited estimate upside” as the primary concern. However, the market’s positive reaction and sustained call buying activity suggested investors were focused on the company’s demonstrated ability to expand margins, generate strong free cash flow, and execute on its strategic transformation—factors that could drive upside beyond near-term consensus estimates.

Restructuring Program Nearing Completion

The bullish options activity comes as 3M’s multi-year restructuring program approaches 90% completion, with cost savings and efficiency gains helping offset pressures from new tariffs and softness in certain end markets. The company has already achieved approximately 170 basis points of margin expansion year-over-year in Q3, with full-year guidance calling for 180-200 basis points of improvement.

The completion of the healthcare spin-off into Solventum Corporation in April 2024 removed capital-intensive operations and simplified 3M’s portfolio, allowing management to focus resources on higher-margin industrial, safety, and consumer businesses. Management has committed to deploying approximately $10 billion from 2025 to 2027 on dividends and share buybacks, demonstrating confidence in sustainable free cash flow generation.

The convergence of strong Q3 results in October, the Barclays price target raise and Goldman Sachs conference on December 4th, and unusual call buying volume on December 8th created an ideal environment for the December 19th call options to capture significant upside. The timing of the call buying on December 8th at 1:18 PM, positioned at the beginning of 3M’s year-end rally toward new 52-week highs, demonstrates the strategic nature of the unusual options activity that preceded one of the industrial conglomerate’s strongest periods in 2025.

MMM was last up 2.53% at $169.56.